Apellis Pharmaceuticals ($APLS) Insider Trading & Smart Money Activity
Apellis Pharmaceuticals, Inc. ($APLS) has 21 13F position changes on file.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 21
- Analyst ratings on file
- 0
APLS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 18 / 3 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All APLS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Verition Fund Management | New | +400K sh | $16.41M | Read | ||||||
| 13F | Tudor Investment | Added | +435K sh | $26.67M | — | ||||||
| 13F | Tudor Investment | Added | +435K sh | $26.67M | — | ||||||
| 13F | Toronto Dominion Bank | New | +1.24M sh | $50.73M | — | ||||||
| 13F | Toronto Dominion Bank | New | +1.24M sh | $50.73M | — | ||||||
| 13F | Rtw Investments | Reduced | -3.98M sh | $151.20M | Read | ||||||
| 13F | Point72 Asset Management, L.P. | Added | +3.59M sh | $171.67M | — | ||||||
| 13F | Point72 Asset Management, L.P. | Added | +3.59M sh | $171.67M | — | ||||||
| 13F | Pentwater Capital Management | New | +5.25M sh | $215.41M | — | ||||||
| 13F | Millennium Management | Added | +1.31M sh | $92.60M | — | ||||||
| 13F | Millennium Management | Added | +1.31M sh | $92.60M | — | ||||||
| 13F | Lmr Partners | New | +403.62K sh | $16.56M | — | ||||||
| 13F | Lmr Partners | New | +403.62K sh | $16.56M | — | ||||||
| 13F | Capstone Investment Advisors | New | +250K sh | $10.26M | — | ||||||
| 13F | Capstone Investment Advisors | New | +250K sh | $10.26M | — | ||||||
| 13F | Balyasny Asset Management L.P. | Added | +1.85M sh | $78.68M | — | ||||||
| 13F | Balyasny Asset Management L.P. | Added | +1.85M sh | $78.68M | — | ||||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -55K sh | — | |||||||
| 13F | Dekabank Deutsche Girozentrale | Sold out | -55K sh | — | |||||||
| 13F | Imc-Chicago | Added | +37.91K sh | $2.43M | — | ||||||
| 13F | Imc-Chicago | Added | +37.91K sh | $2.43M | — |
1W / 1M / 6M = how APLS moved from the trade or filing date.
Institutions moving APLS (13F)
Frequently asked questions
Which institutions changed their APLS positions?
Recent 13F filers moving the stock include Tudor Investment, Toronto Dominion Bank, Point72 Asset Management, L.P., Millennium Management and Lmr Partners.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.